TrialThe New England journal of medicine2026

AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 Trial.

Connor J Lewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.